Search

Finance

Taylor Devices: A Strong Buy Signal Despite Past Challenges

Morgan HouselMorgan HouselAug 21, 2026
This article examines Taylor Devices' recent financial performance and future prospects, highlighting the significance of its substantial backlog increase and strong position in the Aerospace & Defense sector.

Unlocking Value: Taylor Devices' Path to Future Growth

Navigating Past Weakness: The FY2026 Turnaround Story

Despite a challenging fiscal year 2026, Taylor Devices (TAYD) has demonstrated remarkable resilience, underscored by an impressive 154% sequential surge in its backlog, reaching a record $52.8 million. This significant increase fundamentally alters the perception of the company's recent performance, suggesting that previous delays are now translating into concrete orders.

Robust Demand Confirmed: Backlog Growth Beyond Expectations

Even when excluding a one-time $19 million order, the company's backlog stands at a robust $34 million. This sustained growth unequivocally supports management's assertion that demand for Taylor Devices' products remains strong and consistent. The conversion of previously delayed orders into a substantial backlog reinforces confidence in the company's operational capabilities and market position.

Aerospace and Defense: A Foundation for Stability and Growth

A critical factor contributing to Taylor Devices' stability is the composition of its backlog. An impressive 92% of the current backlog is derived from the Aerospace & Defense sector. This concentration provides high revenue visibility and ensures margin stability, laying a solid foundation for financial performance in fiscal year 2027. The inherent long-term nature of defense contracts further strengthens this outlook.

Attractive Investment Proposition: Valuation and Future Upside

From an investment perspective, Taylor Devices presents an compelling opportunity. With a forward price-to-earnings (P/E) ratio of 16, a healthy cash reserve, and a complete absence of debt, the company exhibits strong financial health. Furthermore, analysts project a 25% upside over the next three years, indicating an attractive risk-reward profile for potential investors seeking growth in a stable sector.

Continue Reading

Related Articles